ScienceDex / Researcher record
Gray, Joe W.
- Pdx Pharmaceuticals, Inc. (no department on record)
- Dana-Farber Cancer Institute (no department on record)
From the FY2019 NIH awards this investigator leads as contact PI. The department is the award's.
FY2019 NIH rank #5,318
- Rising Star
- Sustained Excellence
- Program Leader
- Long-Funded
NIH Funding · FY2019
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2001 | $3,049,205 | 2 | #423 |
| 2002 | $1,093,728 | 2 | #3,336 |
| 2003 | $3,410,961 | 3 | #520 |
| 2004 | $5,392,850 | 3 | #204 |
| 2005 | $5,530,860 | 2 | #206 |
| 2015 | $682,376 | 1 | #11,090 |
| 2016 | $672,917 | 1 | #11,538 |
| 2017 | $891,700 | 2 | #8,013 |
| 2018 | $1,416,758 | 2 | #4,721 |
| 2019 | $1,392,831 | 3 | #5,318 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20012 records
- FY20022 records
- FY20033 records
- FY20043 records
- FY20052 records
- FY20151 record
- FY20161 record
- FY20172 records
- FY20182 records
- FY2019 · selected3 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2001 through FY2019Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2019 award records by amount
NIH award records listing Gray, Joe W. as a PI. Multi-PI records show the full award amount for context.
- 5U01CA195469-05U01Contact PIIntratumor heterogeneity underlying treatment resistance in HER2+ breast tumors$645.6Kaward amount
- 6R44CA217534-04R44Contact PINanoparticle-based targeted codelivery of siRNA and taxane to treat drug-resistant HER2+ breast cancer$513.4Kaward amount
- 5R44CA217534-03R44Contact PINanoparticle-based targeted codelivery of siRNA and taxane to treat drug-resistant HER2+ breast cancer$233.9Kaward amount
Award organizations
Organizations that administered FY2019 awards listing Gray, Joe W. as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2001First NIH AwardPdx Pharmaceuticals, Inc.
- 2001$500K Cumulative Funding
- 2001$1M Cumulative Funding
- 2001$2M Cumulative Funding
- 2001Entered Top 50% NationallyRanked #423
- 2001Entered Top 25% NationallyRanked #423
- 2001Entered Top 10% NationallyRanked #423
- 2001Entered Top 5% NationallyRanked #423
- 2002Multi-Institutional ResearchAwards at 2 institutions
- 2003$5M Cumulative Funding
- 2004$10M Cumulative Funding
- 2015Program/Center Grant Leader